On October 24, 2026, the latest industry survey from global veterinary medical device research institutions shows that the global small animal orthopedic medical device market recorded a 9.7% year-on-year revenue growth in the first three quarters of 2026, with the full-year market size projected to reach USD 850 million. Customized orthopedic implants and minimally invasive surgical instruments for cats and dogs now account for over 42% of total market shipments, marking the fastest-growing segment across the entire companion animal medical device sector. As pet owners increasingly view their animals as core family members, small animal orthopedic care has evolved from a niche veterinary service to a high-growth, standardized medical track with massive unmet market demand.

      In terms of product structure, orthopedic implants including locking plates, intramedullary pins and bone screws remain the largest revenue contributor, taking up 57.3% of the total market share. These products are widely used in routine fracture repair, joint reconstruction and deformity correction procedures for small animals. The minimally invasive surgical instrument segment, which covers veterinary arthroscopy systems, high-speed bone cutting burrs and orthoscopic visualization tools, has seen its shipment volume surge 27.4% year-on-year this year, far outpacing the growth of conventional implant products.

      The core driver behind this market expansion is the continuous upgrading of veterinary clinical capabilities and rising pet owner willingness to pay for advanced care. Statistical data shows that minimally invasive orthopedic procedures reduce average post-operative recovery time for small animals from 21 days to 7 days, with post-surgery complication rates dropping by 62% compared with traditional open surgeries. The penetration rate of these advanced procedures in first-tier urban veterinary hospitals has already exceeded 35% in 2026, directly driving the adoption of high-value small animal orthopedic instruments.

      Industry analysis indicates that the top 5 participants in the global small animal orthopedic medical device market currently hold a combined 41% market share. Leading manufacturers are making sustained R&D investments in titanium alloy surface modification, polymer absorbable materials and 3D-printed personalized orthopedic implants, continuously narrowing the performance gap with human orthopedic devices. Local regional suppliers are rapidly gaining market traction by offering localized technical training, same-day clinical support and cost-effective product portfolios, gradually breaking the long-term dominance of international brands in high-end veterinary orthopedic scenarios.

      Notably, the market shipment volume of small animal-specific orthopedic rehabilitation devices, including customized pet braces, joint mobility training equipment and post-surgery pain management devices, has jumped 34% year-on-year in 2026. This emerging segment is expanding the market boundary from surgical intervention to full-cycle orthopedic care. Driven by the growing pet insurance coverage and continuous improvement of specialized veterinary orthopedic capabilities, the global small animal orthopedic medical device market is projected to maintain a compound annual growth rate of over 8.2% from 2026 to 2033, creating long-term stable growth space for the entire industry.